COMMUNIQUÉS West-GlobeNewswire

-
Canada House Wellness Group Announces Issuance of Stock Options
29/06/2018 -
Novartis receives positive CHMP opinion for Kymriah® for treating two aggressive blood cancers, marking important medical advance for patients in Europe
29/06/2018 -
Arch Therapeutics, Inc. $4.5 Million Registered Direct Offering
29/06/2018 -
The American Health Council Selects Sara Safder, MD to Board of Physicians
29/06/2018 -
BioSig Technologies to Present at the Emerging Medical Technologies Spotlight
29/06/2018 -
Tetra Bio-Pharma’s Evidence-Based Business Model Confirmed
29/06/2018 -
Samumed Announces Presentation of Clinical Data Analysis on SM04690 for Treatment of Knee Osteoarthritis at International Workshop on Osteoarthritis Imaging (IWOAI) 2018 Conference
29/06/2018 -
ContraVir Pharmaceuticals Announces $10.8 Million in Expected Gross Proceeds from Recently Expired Rights Offering
29/06/2018 -
Extendicare Announces Timing of 2018 Second Quarter Results and Conference Call
29/06/2018 -
APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor
29/06/2018 -
Change in number of shares and votes in Saniona AB (publ)
29/06/2018 -
Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
29/06/2018 -
Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis
29/06/2018 -
FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers
29/06/2018 -
RavenQuest Announces Media and Investor Open House at Edmonton Facility
29/06/2018 -
Sanofi: Availability of the Pre-quarterly Results Communication
29/06/2018 -
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
29/06/2018 -
Shire plc : Rule 2.9 Announcement
29/06/2018 -
Chi-Med to Announce 2018 Half-Year Financial Results
29/06/2018
Pages